M. Jison

Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.

D. Jayne, Arnaud Bourdin, Michael E. Wechsler, 2024, The New England journal of medicine.

Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety (TATE study)

T. Guilbert, V. Werkström, Takao Fujisawa, 2024, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo-controlled OSTRO trial.

Joseph K. Han, C. Hopkins, Claus Bachert, 2024, British journal of clinical pharmacology.